Table 1.
Subject, No. (%) | |
---|---|
Demographics | |
Male Sex | 4 (30.8) |
Age, years | |
Mean | 69.8 |
Range | 48–82 |
MAC Pulmonary Involvement | |
Non-cavitary | 7 (53.8) |
Cavitary | 6 (46.2) |
Underlying Pulmonary Disease | |
COPD | 6 (46.2)a,b |
Bronchiectasis | 3 (23.1)a,c |
None | 5 (38.5)d |
Pulmonary Cancer Type | |
Adenocarcinoma | 8 (61.5)e |
SCC | 3 (23.1) |
Carcinoid | 3 (23.1)e |
Cancer Treatment | |
Systemic Chemotherapy | 5 (38.5) |
Targeted Radiation | 5 (38.5) |
Surgical Resection | 10 (76.9) |
Abbreviations: COPD=Chronic obstructive Pulmonary Disease, SCC = Squamous cell carcinoma, MAC = Mycobacterium avium complex.
One patient had both COPD and bronchiectasis.
One patient with COPD was also treated with etanercept prior to the diagnosis of MAC pulmonary disease.
One patient with bronchiectasis was diagnosed with lymphoma soon after diagnosis of MAC pulmonary disease.
One patient without underlying pulmonary disease was also treated with everolimus for metastatic renal cell carcinoma.
One patient was diagnosed with both pulmonary adenocarcinoma and pulmonary carcinoid.